R-BMD in Refractory or Relapsed Lymphoma, GELTAMO Clinical Trial
Status:
Completed
Trial end date:
2016-07-01
Target enrollment:
Participant gender:
Summary
Assess the combination of efficacy of the combination of rituximab, bendamustine,
mitoxantrone, dexamethasone in the treatment of patients with Follicular Lymphoma.
Phase:
Phase 2
Details
Lead Sponsor:
Grupo Español de Linfomas y Transplante Autólogo de Médula Ósea